LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,865,000 | -0.5% | 5,000,000 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $4,887,000 | -2.6% | 5,000,000 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $5,016,000 | -0.3% | 5,000,000 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $5,032,000 | +1.8% | 5,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,941,000 | +58.9% | 5,000,000 | +66.7% | 0.00% | +33.3% |
| Q1 2021 | $3,110,000 | +8.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,872,000 | +5.3% | 3,000,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,727,000 | -92.5% | 3,000,000 | -92.9% | 0.00% | -92.9% |
| Q2 2020 | $36,493,000 | -39.9% | 41,980,000 | -42.6% | 0.04% | -48.1% |
| Q1 2020 | $60,706,000 | -29.5% | 73,090,000 | -26.2% | 0.08% | +2.5% |
| Q4 2019 | $86,106,000 | +4.0% | 99,090,000 | +0.5% | 0.08% | -2.5% |
| Q3 2019 | $82,764,000 | -1.2% | 98,640,000 | +1.5% | 0.08% | +3.8% |
| Q2 2019 | $83,789,000 | – | 97,140,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 51,550,000 | $44,471,000 | 3.48% |
| CAMDEN ASSET MANAGEMENT L P /CA | 57,100,000 | $49,298,000 | 1.56% |
| CANYON CAPITAL ADVISORS LLC | 70,000,000 | $60,020,000 | 1.22% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 67,972,000 | $58,675,000 | 1.14% |
| SHENKMAN CAPITAL MANAGEMENT INC | 10,300,000 | $8,952,000 | 1.02% |
| Ferox Capital Management LP | 3,100,000 | $2,674,000 | 0.92% |
| Context Capital Management, LLC | 1,350,000 | $1,169,000 | 0.68% |
| DeepCurrents Investment Group LLC | 4,200,000 | $4,600,000 | 0.39% |
| SSI INVESTMENT MANAGEMENT LLC | 5,600,000 | $4,835,000 | 0.36% |
| WOLVERINE ASSET MANAGEMENT LLC | 29,799,000 | $25,720,000 | 0.34% |